You are on page 1of 13


The worldwide prevalence of hepatitis C virus (HCV) is estimated to be around 3%, representing approximately 170 million infected individuals. Morbidity associated with HCV infection is due not only to the sequelae of chronic liver disease but also to a variety of extrahepatic manifestations, including that involving the oral cavity. In the review that follows, Drs. Carrozzo and Gandolfo discuss the controversial role of HCV in the mechanisms underlying the pathogenesis of two oral conditions—Sjögren's-like sialadenitis and oral lichen planus. — Olav Alvares, Editor

M. Carrozzo* S. Gandolfo Department of Biomedical Sciences and Human Oncology, Oral Medicine Section, C. so Dogliotti 14, University of Turin, I-10126 Torino, Italy; *corresponding author, ABSTRACT: Morbidity associated with hepatitis C virus (HCV) infection can involve a variety of extrahepatic conditions, including lichen planus (LP) and sialadenitis, predominantly or exclusively involving the oral region, conditions which have been largely neglected in reviews. The literature suggests that HCV-infected patients may frequently have Sjögren-like sialadenitis with mild clinical symptoms, whereas oral LP may be significantly associated with HCV infections in Southern Europe and Japan but not in Northern Europe. These geographical differences could be related to immunogenetic factors such as the HLA-DR6 allele, significantly expressed in Italian patients with OLP and HCV. Analysis of experimental data suggests that HCV could be involved in the pathogenesis of both these diseases. Moreover, parotid lymphoma may arise in patients with sialadenitis, mainly with type II cryoglobulinemia. Little attention has been paid to oral health needs in HCV-infected patients and the variable effect of interferon-alpha therapy on oral tissues. Further research is needed, because of the potentially great influence of oral diseases possibly linked to HCV on the quality of life of millions of patients. Key words. Hepatitis C virus, lichen planus, oral lichen planus, sialadenitis, Sjögren's syndrome.

(I) Introduction


epatitis C virus (HCV) is an enveloped, single-stranded positive-sense RNA virus that was isolated in 1989 from a chimpanzee chronically infected by contamination with a human factor VIII concentrate (Choo et al., 1989). Although details of HCV replication are not known, it is thought to take place in the cytoplasm, where, among other products, negative-sense viral RNA (vRNA), replicative double-stranded forms, and non-structural proteins are synthesized. Their presence can thus be used as evidence that virus multiplication, as opposed to passive transportation, is occurring (Negro et al., 1999). HCV has an extremely variable genome, and six distinct genotypes and multiple subtypes have been identified (Pileri et al., 1998). Furthermore, sequence variants forming a quasispecies may circulate within an individual, possibly as a consequence of ongoing immune surveillance and viral mutations (Toyoda et al., 1998). HCV is presently considered the main etiologic agent of both blood-borne and sporadic non-A non-B hepatitis, and is one of the major causes of chronic liver disease worldwide. The overall estimated prevalence of HCV infection is 3%, representing approximately 170 million infected people world-

wide. However, there is great geographic variation in the prevalence of infection. On the basis of studies among blood donors (Wasley and Alter, 2000), the lowest prevalence of antiHCV antibodies (0.01-0.1%) is in the United Kingdom and Scandinavia, followed by slightly higher rates (0.2-0.05%) in Western Europe, North America, most areas of Central and South America, Australia, and South Africa; intermediate rates (1-5%) are reported in Brazil, Eastern Europe, the Mediterranean area, the Middle East, the Indian subcontinent, and parts of Africa and Asia, and the highest HCV prevalence is reported in Egypt (17-26%). The natural history of HCV infection is difficult to assess because of the usually silent onset of the acute phase and the few symptoms seen during the early stages of chronic infection. Acute infection leads to chronic infection in the majority of persons (up to 80%), of whom 20% will eventually develop cirrhosis (Di Bisceglie, 1998). Once cirrhosis is established, the risk of the subject's developing hepatocellular carcinoma is approximately 1 to 4% per year (Colombo et al., 1991). Morbidity associated with HCV infection is due not only to the sequelae of chronic liver disease, but also to a variety of extrahepatic manifestations (Table 1). Most of these are immune-mediated, possibly as a result of virus-dependent pro-

14(2):115-127 (2003)

Crit Rev Oral Biol Med


Xerophthalmia.. 116 Crit Rev Oral Biol Med 14(2):115-127 (2003) . A series of extrahepatic cell types possibly supporting HCV replication has been proposed. 1994 Pirisi et al. lichen planus (LP) and sialadenitis. 2000 Henderson et al. 1993 Pawlotsky et al. 1999). 2000. 1994 Boscagli et al. 1992 Guisset et al. adrenal gland. 1999 Cacoub et al. This was reinforced by a French study finding that 57% of HCV-associated chronic liver disease patients exhibited a grade 3 TABLE 2 Lacrimal or Salivary Abnormality in Patients with HCV Infection Histological Evidence of Sialadenitis (%) 100 49 20 77 60.6h Positive Schirmer test. in most cases. 2002 a b c d e f g h n 28 22 50 61 22 32 23 20 21 1614 321 87 40 45 74 Country France Italy France France France Italy France Italy Sweden France France Australia UK France Spain Xerostomia (%) 35. Percentage of patients with hyposalivation measured by mean of the Salivette system not available. Roy and Bagg. 1994a Poet et al..4d 33d 50f NAg 16. thyroid.. 1997 Verbaan et al. 1998.3a 14a. Lodi et al.. 2001 Loustaud-Ratti et al. two of the most frequently reported extrahepatic manifestations of HCV infection... (II) Sjögren-like Sialadenitis Cases of chronic hepatitis C with mixed cryoglobulinemia and signs of Sjögren's syndrome (SS) first suggested a possible link between SS and HCV infection. 1992 Almasio et al. 2001). Unstimulated and stimulated whole sialometry. lung. and skin cells (De Vita et al.. Notably.7 5 5 11 12 18...TABLE 1 Extrahepatic Manifestations of HCV Infection Hematologic and lymphoid Mixed cryoglobulinemia Aplastic anemia Idiopathic thrombocytopenia Non-Hodgkin's B-cell lymphoma Endocrine Hashimoto's disease Hypothyroidism Hyperthyroidism Diabetes mellitus Dermatologic Leukocytoclastic vasculitis Porphyria cutanea tarda Lichen planus Polyarteritis nodosa Erythema multiforme Erythema nodosum Malakoplakia Urticaria Pruritus Psoriasis Necrolytic acral erythema Still's disease Unilateral nevoid telangiectasia Disseminated superficial porokeratosis Acquired epidermolysis bullosa Salivary gland and ocular Sialadenitis Mooren corneal ulcer Uveitis Renal Glomerulonephritis Neuromuscular and joints Muscle weakness Latent muscular abnormalities Peripheral neuropathy Arthritis/arthralgias Rheumatoid arthritis Autoimmune and miscellaneous Pulmonary fibrosis Pulmonary vasculitis Hypertrophic cardiomyopathy CRST syndrome Antiphospholipid syndrome Granulomas Autoimmune hepatitis types 1 and 2 Presence of autoantibodies Oral carcinoma liferation of monoclonal or polyclonal lymphocytes (Bonkovsky and Mehta.. Laskus et al...4 8 62 8 Hyposalivation (%) 13. One approach used to study the pathogenesis of HCVassociated disease is to follow its replicative pattern in infected tissue and to establish anatomoclinical correlations. the salivary flow rates in HCV+ve patients were significantly lower than those in healthy controls.8 0 11 80 Lacrimal Abnormality (%) 10. and gastric. 45% of the patients had not further defined "lacrimal dysfunctions". 2000. focused on its oral manifestations. Nagao et al.. 2000 Coates et al.. are available (Lodi and Porter. not significantly altered compared with healthy controls.7 0 0 30.. Unstimulated whole sialometry.. Stimulated whole sialometry. involve the oral region predominantly or exclusively.b 50c 26a 0a 57a 11e 12e 31e - Reference Haddad et al.. including peripheral blood mononuclear cells. Some reviews on non-hepatic diseases associated with HCV infection. pancreas.. Detail of the test used not available. links to the various extrahepatic manifestations remain to be proved. however. 2001 Ferreiro et al. oral mucosa. kidney. 1997. 2000c). and spleen.. However. 1996 Taliani et al. 1999 Cacoub et al.

. Notably. although we have 1992. 1995 109 France European 3 from 3 to 75% using second-generation Boscagli et al. 1999. frequently not dependent on the HCV genotype.. lymphocytic infiltration in HCV-infected patients was pericapillary rather than periductal. (1986).. e 1999. hepatitis C patients are histologic or serologic abnormality. Guisset et al.. 1999 98 Spain European 7d using a RIBA-2 technique) has been reported Szodoray et al. since this lesion was found represented by histological signs of mild sialadenitis. Other absent (but may be underevaluated) (Table 2). 1996 18 UK European 0d antibodies in SS primary patients ranging Wattiaux et al.. 1996. 1994. 1999 53 Sweden Copenhagen 2 Conversely.. 1994a).. lymphoma.-globulinemia Barrier et al. and that lymphocytic capillaritis resembled an early stage of disease (Pawlotsky HCV-infected patients may frequently have Sjögren-like et al. Pawlotsky et al. Verbaan et al.. False-positive Loustaud-Ratti et al. Vitali et al. 1993 22 France Na 9 (frequently observed in SS) is present (Marson Vidal et al. Loustaud-Ratti et al. no specific antinuclear (SS-A [anti-RO] and SS-B [antisaliva are more likely to complain of xerostomia (Roy et al. the European-prothan those fulfilling the Fox criteria. 1994).. Pirisi et al.. 1995 100 USA Fox IIe 1 European (mainly Italian and Spanish) Masaki and Hayashi.. 1992 22 Greece Vitali 5 the inclusion criteria (Table 3). Several studies data confirm the lack of relationship between the presence of seem indeed to indicate that this sialadenitis may be signifisialadenitis and particular genotypes (Loustaud-Ratti et al. 1994a. cantly different from that of SS. Much of the work on HCV-ve+a Reference n Country Criteria (%) sialadenitis in HCV infection is not from dental institutions.. whereas in patients infected with each of the three main HCV serotypes clinical evidence of dry mouth and mainly of dry eyes is often present in developed countries (Pawlotsky et al. d ELISA only. 1993 20 France Fox I 10 been reported when hyper. Scott et al.. who reported that the prevalence of SS trative disease. 1999 90 Spain European 14 eration confirmatory immunoblot assay Coll et al. considered as distinct from SS (Roy and Bagg. tion.. the HCV test used. respectively. from 14 to 19% using third-generation Jorgensen et al.. sarcoidosis. Coates et al... 1998).. a RIBA confirmed. with no CONTROVERSY #1 destruction of the salivary gland (SG) ducts. Haddad et al. Marrone et al. 1996 23 France Na 5d ELISA.. milder histopathology (with a CD8+ rather than a CD4+ virus in the saliva (Ferreiro et al. 2001. 1995.. 1992 26 Italy Fox I 0 HCV-infected. 2001 213 Hungary European 6 in USA and UK studies (King et al. Further data (Almasio et al. 1991. ing diseases such as hepatitis C. Boscagli et al. 2000) (Table 3). 1994 26 Italy Na 4 matory tests are clearly recommended so that King et al. 1992).. and in the posed (including Vitali and Copenhagen) criteria can be fulfilled without a requirement for latter classification. Taliani et al.. Porter et al... 2002). Ferreiro et al. 1992). and thus there are few availFerri et al. the number of patients fulfilling the b Not available. The last Fox classification excludes patients with a history of pre-existhas been highlighted by Laustaud-Ratti et al. 1997 26 Spain European 19d (RIBA) (Ramos-Casals et al... 1996 62 France European 19 ELISA. few data on lachrymal and salivary function in these patients. 1997). lower HCV prevalence (0-1% Selva-O'Callaghan et al.. There is no female predomi2001).. In contrast. 1994b). De Bandt. 2000. 1994a. Indeed. Cacoub et al. and fewer clinical symptoms (Pawlotsky et al. the frequency varying with the Vitali et al. 14(2):115-127 (2003) Crit Rev Oral Biol Med 117 . 1995 98 Japan Na 11d authors have reported prevalence of HCV Porter et al.. 1968. 1991 20 Italy Nab 5 able data on the prevalence and effect of Marson et al. T-cell predominance). or other causes of lymphocytic infil(2001).. 1992 26 France Na 8 immunoenzymatic (ELISA) HCV tests have Mariette et al. 2000.. (III) Pathogenesis of HCV-related Sialadenitis Henderson et al. 1991 20 Italy Fox Ic 0 hyposalivation in such patients. 2001)... 1994 44 USA Na 0 bias can be avoided. a less frequent association with the HLA-DR3 but whole salivary flow is not associated with the presence of the allele. Poet et al. 1994 28 France Fox I 14d et al.... 1993. 1997 31 Spain European 10 Fernandez-Campillo et al. It has been reported that patients with HCV-RNA in the nance. Verbaan et al. 1992 20 France Na 10 from 0 to 19% of patients with frank SS can be Aceti et al....... and Vitali et al. 1996). 1997. This problem Fox and Saito (1994). 1994. 1992. HCV may be present in the saliva of 83% of patients with HCV-associated sialadenitis TABLE 3 (Jorgensen et al.... Fox et al. in contrast to SS.. 1994. Haddad et al. 1992 44 Italy Vitali 5 geographical region. European criteria is five.. 1999. LA]) antibodies.. 2001. A subsequent study noted that. and thus confirFrisoni et al.. 1996) and is also detectable in Association of HCV Infection with Sjögren's Syndrome tears in concentrations higher than serum (Feucht et al. In contrast to the Fox (San Diego) classification system... and from 5 to 19% using second-genGarcia-Carrasco et al. 1994.. sialadenitis with mild clinical a cohort of 45 French HCV-infected patients increased from or 4 sialadenitis (according to Chisholm and Mason's classifica8% to 38% according to the Fox and the European criteria. VIRAL FACTORS 2002) have shown that up to 80% of HCV-infected individuals An early study suggested that the presence of sialadenitis was may have some salivary or lachrymal ten-fold greater c Fox et al. several Marrone et al.. Pirisi et al.

The model also predicts that xerophthalmia.7 13.7 NA 3. 1974). but it seems unlikely to be induced by an immune reaction against ductal cells expressing viral antigens.. HCV is uncommon in SS patients without mixed cryoglobulinemia (King et al.. which are able to infect the salivary glands of their arthropod vector. et al. Verbaan et al. 2001). 1982 Rebora and Rongioletti. 1994 a b c d e f Country Italy Italy USA Denmark USA USA UK UK Italy Italy Spain Italy Italy UK Spain Study Group 37LPb 44LPb 389LPb 54OLP 73LPb 15OLP 55LPb 113OLP 21OLP 62LPe 65OLPb 577LP 96OLP 180OLP 187OLP Cirrhosis (%) 1... However. 1991).5 9. 2001). since only one out of 20 transgenic mice showed a weak antibody reaction to E1 protein. rarely reported in HCV-infected patients. 1995. 1974). closely resembling the Chisholm and Mason grade 3 or 4 sialadenitis noted in humans (Haddad et al. or of polyclonal IgG and IgM (type III) (Brouet et al. 1988 del Olmo et al..1 38....3 3. 1999).5 10.CRYOGLOBULINEMIA The term 'cryoglobulinemia' refers to several syndromes characterized by the presence of abnormal proteins (cryoglobulins) that precipitate from cooled serum (Brouet et al. whereas 80 to 100% have HCV infection (Dammacco et al. 2001).7 0. would be a late development.7 12e 13... HCV antigens have been immunohistochemically detected in SG epithelial cells (De Vita et al.52 5.5 33..0 NA NA 52.. Significantly different from the control groups.1 100 17... According to the composition of the cryoprecipitates. 2001).8 21. 1992a el-Kabir et al.2 - Including abnormal liver function tests.9 25.or interleukin 2 by HCV proteins or the induction of an immunological disturbance by the transgene. 1984 Korkij et al.87 7.6 0.and negative-strand HCV-RNA has been detected in minor SGs of patients with sialadenitis and chronic hepatitis C by PCR and in situ hybridization (Takamatsu et al. 1984d Katz and Pisanti. This model clearly suggests a direct role of the viral proteins in the pathogenesis of HCV-related sialadenitis. Nests of lymphatic infiltrates were also noted in the LGs... 1980).5 11. About 15% of patients with MC have SS (Gorevic et al. not all the HCV-positive patients with evidence of salivary gland abnormalities have detectable serum cryoglobulinemia (Pawlotsky et al.. 1997). an animal model of transgenic mice carrying the HCV envelope genes E1 and E2 has been constructed (Koike et al. 1985 Monk. because lymphocytic capillaritis preceded sialadenitis. and Chronic Liver Disease Chronic Erosive LP (%) Hepatitis (%) NAc NA NA 70. However. it became evident that cryoglobulinemia is the most frequent extrahepatic manifestation of the virus (Dammacco et al. 1999). The pathogenesis of this sialadenitis in transgenic mice is unclear... 1993d Bagan et al..7 4. After the identification of HCV..3 NA 4. primary biliary cirrhosis and liver lymphoma). positive. 1997). other liver diseases (e. 1990d Gandolfo et al.0 NA NA 9.g. TRANSGENIC ANIMAL MODEL Recently. cryoprecipitates are composed of polyclonal IgGs against HCV and monoclonal IgM rheumatoid factors (type II).0 25.3 7. The mice developed an exocrinopathy involving the SGs and lachrymal glands (LGs) in 84% of cases. Biasi TABLE 4 Studies on the Possible Association among Lichen Planus (LP). 1985 Ayala et al. Precise characteristics of LP not stated. 2001). 1990 GISED.. 1994a. both these cryoglobulinemias are designated as mixed cryoglobulinemia (MC)..5 11. Initially. Whereas SGs of patients with chronic HCV infection but without clinical and histological signs of sialadenitis were not infected (Taliani et al. Case-control studies. 1985 Scully et al. 1992. and the infected cells did not show any differences with respect to unaffected ones (Arrieta et al.3 42.3 14. Moreover. Loustaud-Ratti et al.7 NA 100 NA 22. No significant difference from the control groups. abnormal liver scan. 1992).3 3.. In particular.0f 21.. In most HCV patients. 1995) but not invariably (Verbaan et al. 118 Crit Rev Oral Biol Med 14(2):115-127 (2003) .9 61. DIRECT INFECTION OF SALIVARY GLANDS HCV is distantly related to flaviviruses (Houghton et al.. but soon focal infiltrates of small lymphocytes appeared.6 7. 1984 Powell et al. Not available. HCV seems to infect and replicate in epithelial cells of the SG acini.8 33. this may reflect the pathological sequence in Sjögren-like sialadenitis occurring in human patients. but they occurred later and were less extensive than those found in the SGs. there is no correlation between the percentage of infected SG epithelial cells and the serum HCV-RNA titer.2 7. 1994. 1984 Mobacken et al. Alternative explanations include the induction of interferon. Arrieta et al.4e 24... Oral Lichen Planus (OLP).3 1... 1986 Cottoni et al.2 Liver Abnormalities Overall (%)a 13.4 Reference Rebora et al.. pericapillary lymphocytes were found.

.. and 22 (40.8 44 20 23 0 0 0 23 13. In a minority of patients.. 1995 Sanchez-Perez et al.. 1998 Rossi and Colasanto.4d 3.8 55 17 45 0 0 6. Only 19 patients were tested.9 20...2 NA NA NA 34. 2002 Ilter et al. Probably..7c 10c 1. or superantigens. 1995a Tanei et al. 1998 Divano et al.3d 3d 3d 6.. 2000).4d NA NA 1. 1994 Gandolfo et al. chronic.. 1996 Serpico et al. 2001 Ibrahim et al. 1994 Schmitt et al. 1992 Rebora.5c 1... Six (22%) with oral lichen planus and 21 (78%) with lichenoid reactions.2 14 23 9. persisting for more than 20 years without spontaneous remission (Scully et al. 2000 Not available.. 2001 Eisen. Significantly different from the control groups. and recalcitrant than the cutaneous type.9%) had cutaneous. 1998 Kirtak et al.8 4.1f 32 28.. 1997 Mignogna et al.... OLP is unlikely to be caused by a single antigen.9 8. Eleven (20. 14(2):115-127 (2003) Crit Rev Oral Biol Med 119 .. 1998 Ingafou et al.... 1999 Figueiredo et al.1d 8 4.. (IV) Lichen Planus Lichen planus (LP) is a chronic inflammatory disease that affects skin and mucous membranes of squamous cell origin. 1999 Beaird et al. 1999 Roy et al. 2002 Van der Meij and van der Waal.CONTROVERSY #2 Analysis of experimental data suggests that HCV proteins play a direct role in the pathogenesis of sialadenitis.. 1997). OLP is the common outcome of the influence of a limited range of extrinsic antigens. precipitating factors have been identified. No significant difference from the control groups. 2000 Erkek et al. 2000 Nagao et al. Only patients with severe liver disease were tested. 1996 Bagan et al. 1997 Chuang et al. 2000 Bellman et al.7 21.. Prevalence data taken from the general population of São Paulo.7%) had mucocutaneous lichen planus.4d 5d 0c 3c 4. four genital).8 13 62 37. The oral form of LP (OLP) seems more common.7 27. 1995 Egan and Zone. given that studies of T-cell receptor variable region genes from lesional OLP T-cells have not revealed the use of a restricted number of different variable region genes (Thomas et al. 1997 Grote et al. 21 (38.8 12. 1995 Carrozzo et al..9 29 16 4.4%) of the 54 patients had mucosal (seven oral.1d NA NA NA NA NA NA 2.e 32 70b 100b 263b 100b 45b 45 25 78 100b 55b 45 27g 30 29b 22 24 31b 195b 72 73 54h 43 68b 55b Controls (n) 112 306 87 100 70 100 100 45 18 82 100 110 32 41 40 20 75 73 54 30 1059i - France Germany Italy Japan Spain UK USA Turkey Egypt Brasil Netherlands a b c d e f g h i Cribier et al. All oral LP. These include dental materials (mainly dental restorative TABLE 5 Prevalence of Hepatitis C Virus Infection in Patients Affected by Lichen Planus Country Reference Study Group HCV+ve HCV-RNA (%) (%) 3.4 NA NA NA 60 NA NA 16 NA NA NA 0 16 NA NA NA NA NA NA NA 9.4d NA NA NA NA NA NA NA NA NA NA NA - LP (n) 52 102b 28b 83 24b 46 56 105b. altered self-antigens. 2001 Chainani-Woo et al. 1994 Dupin et al. 1998 Imhof et al.6c 4.... 1995 Gimenez-Arnau et al..7d 5d 2.8 0 NAa NA 18 14 4. 1997 Dupond et al. although it seems unlikely that sialadenitis is induced by direct infection of salivary glands or by an immune reaction against ductal cells expressing viral antigens.8d 25d 5d 0c 1.5 34.3 NA NA 0 Control Group HCV+ve HCV RNA (%) (%) 2. 1998 Tucker and Coulson.

Erkek et al.. 2001).. 1996. 1996.... and it appears to be uncommon in the UK (Harris et al... drugs (such as non-steroidal antiinflammatory drugs and angiotensin-converting enzyme inhibitors). Markers of past hepatitis B virus (HBV) infection (antibodies to hepatitis B surface antigen [HBsAb] and to hepatitis B core antigen [HBcAbIgG]) have been reported in 21 to 30% of Spanish and Italian patients having LP (Ayala et al... 1994.. 1996a). Tucker and Coulson. 1995. 1997. 1997. 14(2):115-127 (2003) 120 Crit Rev Oral Biol Med .and B-cells among infiltrating lymphocytes regardless of the presence or absence of HCV infection (Kirby et al. Carrozzo et al. Grote et al. Chuang et al. 1994. sex.8 to 4. 2000) and have suggested that HCV could be involved in the development of LP. but this prevalence is near the average figure in the Mediterranean area. whereas the association of LP with primary biliary cirrhosis is mostly due to the administration of penicillamine treatment (Graham-Brown et al.. especially in Mediterranean patients with oral erosive LP (Gandolfo et al. Oleaga et al. Schissel and Elston. Gandolfo et al. Agner et al. Hyrailles et al..6 to 20% of patients with HCV-related chronic hepatic disease may have LP (Pawlotsky et al.. 1993. Nagao et al.. but a recent controlled study reported that the reticular and plaque clinical forms are prevalent as well (Mignogna et al. 1994.. and alpha-1-antitrypsin deficiency have rarely been related to LP (Rebora. 1994. Divano et al. 1994.. Daoud et al. Carrozzo et al. Calista and Landi. 1998.. 1992b). though mainly genotype 1b seems associated with LP. 1996. Spain. Benchikhi et al. since 1991. 1998). 1995. Analyses of early data suggested that mainly oral erosive OLP may be linked to HCV infection (Gandolfo et al.. and infectious agents (including herpes simplex virus I. 2001). Jauregui et al. On the other hand. 1993... especially the oral variety (Table 5). herpes virus 6.. since 7. Beaird et al.. Cayla et al. 1986.. 2000. In contrast to the Mediterranean data. 1992.. Bagan et al. 1995.. 1998. Lodi et al. 1997a. 1996). 1985. mainly of the oral cavity. Moreover. 2001). 1994. 1999).. 1982. OLP would probably be more easily identified in HCV-infected patients in countries with low levels of HCV. 1995. Roy et al. 1994). 2000.. 2001.. 1995)... Carrozzo et al. Japan.... Several controlled experiments have confirmed that HCV is the main correlate of liver disease in patients with LP (Carrozzo et al. this difference seems only partially related to the level of endemism of HCV in the general population.. 2001. 1995) was probably influenced by the prevalence of HCV in the general population. 1998. 1998. Kirtak et al. Apparently. whereas a study from southern France (Nice) reported 29% of HCV-positives in 28 patients with erosive OLP (Dupond et al. are clearly needed. HCV-associated hepatic disease may precede LP onset or may be diagnosed together with it. 1997b). 1997.. 1994. 1992. Henderson et al.. and Helicobacter pylori and hepatitis viruses) (Scully et al. 1991. whereas investigations in England and Holland (Ingafou et al. (V) Pathogenesis of HCV-related LP (A) VIRAL FACTORS The role of particular HCV genotypes in the pathogenesis of HCV-related OLP is ruled out by the observation that LP can be associated world-wide with the same genotypes commonly found in patients without LP (Pawlotsky et al. there are no significant differences in the histopathological characteristics specific to OLP or in the ratio of T. 2000).. 1984... CONTROVERSY #3 LP. 1993. Nevertheless. Jubert et al... Almost all data from Italy.. Bez et al. 1998. 1998... hepatitis G virus and TTV. 1995. Tanei et al. However. There are also controversial data from Germany and Turkey (Imhof et al.. 1995. 1996. 2000. On the other hand.... Gimenez-Arnau et al. retrospective and prospective studies of Scandinavian and British OLP patients have failed to show any significant correlation with liver diseases (Mobacken et al.9% in their sixth decade were HCV-infected (Hayashi et al. 2000b. 2000a). Schmitt et al. Figueiredo et al. Scully et al. Dupin et al... but no hypothetical pathogenic correlation could be found until sensitive hepatitis C virus (HCV) assays became available. 1997). Eisen. the majority of patients with both LP and CLD are not HBV-infected (del Olmo et al. 1982.. a smallscale study from Egypt.. Mouly et al. 1994. Curiously.. haemochromatosis. Grote et al. Tanei et al. the picture appears quite complicated: Low prevalence of HCV infection ranging from 3. are not associated with LP (Pedersen. cytomegalovirus.9% was found in OLP patients from northern France (Strasbourg) and Ile-de-France (Paris) (Cribier et al.materials such as amalgam). 1999). 1995a... 1998. did not report a significant association between LP and HCV (Ibrahim et al. possibly reflecting the low incidence in those populations. Brazil. 2001). 1998. The frequent association of LP with chronic liver disease (CLD) is well-known (Table 4). Amichai et al. However. The risk of chronic liver disorders in LP patients is in fact independent of age.. el-Kabir et al. Well-designed prospective studies.. 1995.. Epstein-Barr virus and the recently discovered viruses. Nagao et al. and all but one study in the USA support the existence of a relationship between LP and HCV infection (Divano et al. stress. Dupin et al. 1990). There are also a few reports of mainly skin lichenoid eruption following administration of different HBV vaccines (Rebora et al. such as the UK (Carrozzo.. 1999). Rodriguez-Inigo et al. mainly those coming from southern regions (Kyushu) (Nagao et al.. 1992. the very high prevalence of HCV infection among Japanese LP patients (38 to 62%). mainly from countries with low prevalence of HCV infection. Coates et al. Nagao et al. 1990. trauma.. Mignogna et al. 2000. Rossi and Colasanto. Ilter et al. Powell et al... Tanei et al. Strumia et al. Bellman et al. 1997.. 2001. 1990. 1994. Sanchez-Perez et al. In France. Chainani-Wu et al.. Lodi et al. more than 80 case reports worldwide have supported the link between LP and HCV infection (Mokni et al. Because these prevalences are generally higher than expected. 1996. Serpico et al. and alcohol consumption.. 2002. Carrozzo et al. 1994. 1994a.. 1992).. 1995a. Epstein-Barr virus. and is still significantly high after adjustment for a positive hepatitis B surface antigen (HBsAg) reaction (GISED.. Wilson's disease. 1999.... 1996). 2000). 1993). 2000. 1996. van der Meij and van der Waal. Pellicano et al. The few studies investigating the frequency of LP among HVC-positive subjects showed that from 1.. 2000.. Sassigneux et al. Studies have also shown no differences in serum levels or HCV-RNA levels between HCV-infected patients with LP and those without (Nagao et al. del Olmo JA et al.. Toure et al. 2001)... appears to be significantly associated with HCV infection in southern Europe and Japan but not in Northern Europe. Bellman et al.. del Olmo et al. which has the highest reported prevalence of HCV infection in the general population. 2000) did not find HCV antibodies in LP cases. Rebora. 1998. 2001.. Gandolfo et al.. 1996). 2002.. Rebora. 1999. Nagao et al.. human papilloma virus... 1995b.. Cecchi et al. 2002). Mignogna et al.

to ameliorate (Doutre et al. In any case. 1997. in vivo. 2001).. In situ and peripheral blood-derived T-cell lines were able to proliferate and to produce gamma interferon upon stimulation with structural and non-structural HCV antigens. 1995.. 1998).. 1996b.. 2002).. 1999. Sassigneux et al. Cayla et al. most OLP-HCV+ve cases do not have this type of auto-antibody (Carrozzo et al.. Perreard et al. The lympho-mononuclear infiltrate typically found in oral lichen lesions rather suggests that the progressive destruction of the oral mucosa lining is due to local immune aggression. mainly in cases with oral involvement (Agner et al. 1998). 2000. Tcell clones present in the oral mucosa showed a TCR-V chain usage different from those circulating in the peripheral blood. 1995a).. 1999). although anti-epithelial antibodies have been detected with significantly higher frequency in patients with HCV-related OLP than in those without HCV infection (Lodi et al. Both in situ hybridization and extractive PCR techniques revealed the presence of replicative intermediate HCVRNA in OLP specimens (Arrieta et al. whereas secondary LP as well as OLP is not. at least in Italy.) for more than 6 months (Lodi et al.. 2002). porphyria cutanea tarda (PCT). HCV-related OLP appears to be associated with the HLA-DR6 allele in Italy (Carrozzo et al. Mariette. all but two of the samples studied were from persons not infected with HCV. Lymphomas occurring in both diseases share several characteristics: predominance of low-grade. 1997a). Lodi et al. 1995. Nagao et al. 1995). and their pathological significance is probably negligible in the absence of -IFN therapy. Moreover. 2000c... of chronic HCV infection (Ferri et al.for a period of 12 months can induce anti-epidermal auto-antibodies.. 1997a. Oral verrucous and squamous cell carcinomas have been reported in HCV-infected patients with or without OLP (Nagao (D) DIRECT INFECTION OF LP LESIONS There are few data on the localization of HCV antigens in LP. the effect of -IFN therapy for HCV infection in patients with LP differs markedly from case to case. it has been reported that PCT susceptibility is different in British and Italian patients. Analysis of experimental data strongly suggests that HCV is involved in the pathogenesis of OLP via local induction of an immune response specific for HCV epitopes. 1994. 1993.. This does not seem to be caused by an elevated frequency of non-organ-specific autoantibodies (Carrozzo et al... However. 2000c. Erkek et al. 1997a). Nagao et al... 2001). 2002). Carrozzo et al.. 62% of the OLP-HCV+ve patients with circulating anti-epithelial auto-antibodies had been treated with alpha interferon (IFN... 1997).(B) MOLECULAR MIMICRY A constant feature in LP patients with HCV infection is the presence of polyclonal hypergammaglobulinemia (Carrozzo et al.. marginal zone histological type. 1999). Nunez et al. 1993.. 1991. Fornaciari et al. often of a lichenoid type (Sookoian et al. 1997... geographic heterogeneity in the prevalence of HCV infection similar to that observed in OLP patients was also found in patients with other extrahepatic abnormalities linked to HCV infection... Hildebrand et al.. the USA. analysis of some data suggests that OLP lesions may contain both genomic and antigenomic HCV-RNA (Arrieta et al. and hypergammaglobulinemia should rather be linked to cryoglobulinemia (Carrozzo et al. in both diseases.. The occurrence of B-cell non-Hodgkin's lymphoma is a complication of SS and. (1996) have shown. frequency of mucosal localization. 1997b). 1998). and showed the same specificity. Protzer et al. However. Lamoril et al... 2000. neous LP. Guijarro et al.. Carrozzo et al.. 2001). For unknown reasons.. McColl et al. 1995. In this study.. Nagao et al. being correlated with mutation in the human leukocyte antigen (HLA)linked hemochromatosis gene C 282Y in the former and to the H63D gene and HCV in the latter (Elder and Worwood. 1996.. 1995.. Zuckerman et al. This striking fact suggests the existence of possible genetic differences among different populations... 1997.. 2001). 1998. Furthermore. 2001).. Indeed. 2000c. sequence analysis suggests a possible compartmentalization of HCV in the oral mucosa (Carrozzo et al. Areias et al. 1996.. (C) GENETIC FACTORS Interestingly.. Luppi et al.. Papini et al. such as serum autoantibodies. The adjuvant use of ribavirin with -IFN also seems to increase the risk of adverse cutaneous reactions. 1999). Using sensitive extractive PCR. mainly associated with type II cryoglobulinemia or SS. 1999.. 1992.. or to trigger or worsen LP lesions. 1998. Ascoli et al.. 2001). Carrozzo et al. CONTROVERSY #4 Immunogenetic factors partially explain the geographic heterogeneity of the association between HCV and LP. that low-dose IFN.. Indeed. 1996. tetramer assays with four different HCV antigens showed that the frequency of HCV-specific CD8+ T-cells was higher in mucosa tissue than in the blood (Pilli et al. 1996.. whereas data on any effect on the oral mucosa are still lacking... however. Varela et al. d'Agay-Abensour et al... Barreca et al. investigators detected positive and negative strands in 82 to 93% and 21 to 36% of the OLP tissue specimens. 1999). It has been proposed that. 1994. Two studies used various immunohistochemical techniques to look for HCV antigens in paraffin-embedded sections of cuta14(2):115-127 (2003) Crit Rev Oral Biol Med 121 . the first event of lymphomagenesis is chronic stimulation at the site of the disease of polyclonal B-cells capable of secreting rheumatoid factor (De Vita et al. Heintges et al. association with asymptomatic low-level cryoglobulinemia (De Vita et al. 1994. 1995) or formalin-fixed (Boyd et al. 2001). 1998). Dalekos et al. However. 2002). but all samples failed to take up the stain. molecular mimicry between the virus and host epitopes is unlikely to be active in LP. and this could partially explain the peculiar geographic heterogeneity of the association between HCV and LP. possible transformation into a large Bcell lymphoma. Recent data have shown that HCV-specific T-cells can be found in the oral mucosa of patients with chronic hepatitis C and LP (Pilli et al. Strumia et al. Luppi et al. (VI) Other Diseases Some cases of parotid gland lymphoma in Italian patients with HCV infection have been reported (De Vita et al. 2000.. either frozen (Sansonno et al. Schlesinger et al. ManjónHaces et al. and lymphoma (Lenzi et al.. 2000).. HCV is probably unlikely to cause direct damage to epithelial cells in OLP lesions.. 1995. 1993. since it was also found in normal mucosa (Arrieta et al. 1996.. 2001). and Japan.. Pedersen. 1993. and Fleishmann et al.. 1992... Nagao et al. whereas no HCV intermediate RNA was detected in skin specimens of LP. although HCV-RNA may be occasionally detected in lesional skin (Mangia et al. -IFN has been reported to have no influence (Pawlotsky et al. 1997. Most idiopathic LP is related worldwide to the HLA-DR1 (DRB1*0101) allele (La Nasa et al. 1992.. Nagao et al. 1994. Mariette. respectively (Nagao et al. Conversely.

In situ detection of hepatitis C virus RNA in salivary glands. (1999). Cacoub P. Scimemi M. Martelli M. The relation between lichen planus and hepatitis C: a case report (letter). In contrast. Habibeddine S. Seligmann M (1974). Why some patients tolerate HCV in the oral mucosa without developing histological lesions. REFERENCES Aceti A. Fairley JA (2001). Carletto A. 1997c). Velho GC. J Am Acad Dermatol 35:770-772. Penarrocha M. unknown. Carrozzo M. Craxi A. Nanney LB. Jarmouni R. Magadur-Joly G. Rodriguez-Inigo E. Oral Surg Oral Med Oral Pathol 78:337-342. probably via an immunological pathway still to be defined. Almasio P. Boscagli A.T. Lazarov A. Canva-Delcambre V. This work was supported by the M. 1997. Danon F. Amichai B. Rodrigo JM. Acta Gastroenterol Belg 58:465-459. Barbedo C. 1998). Hepatitis C: a review and update. et al. Lichen planus and chronic hepatitis C: exacerbation of the lichen under interferon-alpha-2a therapy. 1995b. Lo Muzio et al. Generalized lichen planus associated with hepatitis C virus immunoreactivity. (1996). Ramon C. for his helpful comments. 1997..U. Mehta S (2001). Poynard T. Cascio G. Taliani G. Provenzano al. Eur J Gastroenterol Hepatol 7:367-368. Bez C. both positive and negative HCV-RNA strands were detected in oral cancer tissues (Nagao et al. 1996c.S. Lancet 346:1234. HCV and Sjögren's syndrome. Ayala F. Rosenthal E. Carrozzo et al. Milian A. Pagliaro L (1992). Diago M. Barrier JH. Conclusions Based on findings in the literature. Franco J. Sanches M. Ascoli V. but further data are required for these preliminary observations to be confirmed and their significance clarified. and HCV is a common cause of liver cirrhosis. Bonkovsky HL. Clauvel JP. Am J Clin Pathol 109:600-609. Le VHC: un agent etiologique improbable du SGS (letter). (1998). Agner T. Rolandi E (1995). (2001). J Am Acad Dermatol 44:159-182. J Am Acad Dermatol 44:311-312. et al. Tranfaglia A. Lack of association between transfusion trasmitted virus and oral lichen planus in British and Italian populations. Ortiz-Movilla N. Balato N. Biologic and clinical significance of cryoglobulins. whereas the link between oral carcinoma and HCV is weak and possibly influenced by the presence of liver cirrhosis. Caramashi P. Hepatitis C virus and Sjögren's syndrome. Amaral B. A prospective multicenter study of 321 patients. Extrahepatic manifestations of chronic hepatitis C. Groupe d'Etude et de Recherche en Medecine Interne et Maladies Infectieuses sur le Virus de l'Hepatite C. University Hospital. Biasi D. Bartolomé J. Halevy S (1994). Preliminary investigation of the association of oral lichen planus and hepatitis C. Negro F (1998). Extrahepatic manifestations associated with hepatitis C virus infection. Cohen P. Nejjam F. Arthritis Rheum 42:2204-2212. further research is needed. Oral erosive lichen planus and chronic liver disease. 1998. Artini M. Areias J. Eur J Gastroenterol Hepatol 8:825-828. (1994). Hepatitis C virus infection and oral erosive lichen planus. Weismann K (1992). J Am Acad Dermatol 14:139-140. Garibaldi A. 1998). Bagan JV. Lo Coco F. Department of Gastroenterology and Hepatology and of Clinical Pathology. Bellman B. Calista D. and the virus may be involved in the pathogenesis of both diseases. Kahloon N. to explore the oral condition of patients with HCV infection. MULTIVIRC Group. A report of 86 cases. Lichen planus associated with hepatitis C (letter). (2000). et al. Scully C. Multidepartment Virus C. Milian MA. Paris C. Gandolfo S. Rodriguez-Inigo E. at present. Franceschini R. Corrocher R. (2000). Oral lichen planus and chronic liver disease: a clinical and morphometric study of the oral lesions in relation to transaminase elevation. King LE Jr (1998). Aguirre JM. del Olmo JA. Klein M. Int J Dermatol 37:260-262. J Dermatol 21:783-784. Lichen planus and hepatitis C. Pardo M. Francesco Negro. and why others will develop OLP or sialadenitis apparently independently of the local viral load is. Amendolea MA (1992). Cervoni. Switzerland. Beaird LM. Olivi M. Bartolome J. Cacoub P. Gassin M (1993). Lichen planus. Am J Pathol 158:259-264.. Acknowledgments We would like to thank Dr. Corsini G. Arrieta JJ. Arrieta JJ. Immunoperoxidase evaluation of lichen planus biopsies for hepatitis C virus. Landi G (2001). et al. Acta Derm Venereol 72:380. et al. Guadagnino V. et al. Orlando R (1986). Lodi G. (1996). Colombari R. et al. Reddy RK. Loury I. Because of the high global prevalence of HCV infection and the potentially great influence that oral diseases possibly linked to this virus may have on the quality of life of millions of patients. Manzarbeitia F. Syndrome sec et infection par le virus C de l'hepatite: un pseudosyndrome de Gougerot-Sjögren? Rev Med Interne 17:375-380. (1995). The GERMIVIC. et al. Achille A. Medicine (Baltimore) 79:47-56... 1996..(with and without ribavirin) therapy on oral tissues. Ann Dermatol Venereol 121:547-549. (2001). Charlotte F. Carrassi A. Piette JC. Casqueiro M. Cerqueira R. Sorice M.R. Falanga V (1996). Janin A. Lancet 339:1425-1426. Extranodal lymphomas associated with hepatitis C virus infection. (ex quota 60%) and the Department of Biomedical Sciences and Human Oncology. University of Turin. Cors R. Ghillani P. Levrero M. and 14(2):115-127 (2003) 122 Crit Rev Oral Biol Med . Barreca T.. Hatron PY. Lancet 339:989-990. Nagao et al. Bagan JV. HCV prevalence is generally not increased in patients with potentially malignant oral lesions such as leukoplakia (Carrozzo et al. Am J Med 57:775-788. Little attention has been paid to the prevalence and the effect of sialadenitis-induced hyposalivation on oral health in HCV-infected patients and to the variable effect of IFN. Loustaud-Ratti V. which may itself represent an independent risk factor for the development of oral cancer (Sorensen et al. Presse Med 22:1108. et al. Manzarbeitia F. erythema nodosum. Reddy R. Br J Dermatol 145:990-993. Hepatology 32:97-103. Oral Surg Oral Med Oral Pathol Radiol Endod 85:532-536. 2000c). et al. Boyd AS. although the epidemiological relevance of this observation is unclear. Detection of hepatitis C virus replication by in situ hybridization in epithelial cells of anti-hepatitis C virus-positive patients with and without oral lichen planus. OLP and sialadenitis may be significantly associated with HCV infection. Porter et al. Hachulla E. Gambini C.. 1999. Incidence of hepatitis C in lichen planus. Fogh H. Renou C. Geneva. Lichen planus induced by interferon-alpha-2a therapy for chronic active hepatitis C. Falanga V (1995). Bellman B. Lakhdar H (1994). Brouet JC. Parotid lymphoma may arise in patients with Sjögren-like sialadenitis with mainly type II cryoglobulinemia. Gonzales L. HCV RNA detection in parotid gland biopsy in a patient with chronic hepatitis C virus liver disease. Herrero M. Benchikhi H.

Dupond AS. Szpirglas H. Coll J. Beylot-Barry M. Sansonno D. Del Ninno E. (1999). Rodrigo JM. Dermatology 188:239-240. Cribier B. Fischer R. Hermida Prieto M. Egan CA. Gastroenterol Clin Biol 16:610-611. Parodi A. et al. Quinton A (1996). Esteban JI. liver kidney microsomal (LKM1) antibodies and hepatitis C virus antibodies. Gastroenterol Clin Biol 20:709-710. et al. Chuang TY. Serra MA. Gloghini A. Long P. malignant potential. (2000). Lichen planus and hepatitis C virus infection: an epidemiologic study. Kuo G. and immunologic involvement. Conrotto D. GijonBanos J (1997). De Vita S. Hepatitis C infection and associated oral health problems. Sangiovanni A. Ann Dermatol Venereol 125:676-678. J Am Acad Dermatol 46:207-214. Cervoni E (1998). Labial salivary gland biopsy in Sjögren's disease. Cayla JM. J Am Dent Assoc 132:901-909. Cecchi R. Chronic hepatitis C and skin diseases: a review. Colombo M. Lacour JP. Lancet 31:351-355. Worwood M (1998). Chisholm DM. et al. Tomas S. J Oral Pathol Med 28:16-19. Serra MA. Fasano ME. Ferraccioli G. Sorrentino D. Increased frequency of HLA-DR6 allele in Italian patients with hepatitis C virus associated oral lichen planus. Carbonero C. (1995). de Belilovsky C. Daoud MS. Dolcetti R. Gandolfo S. Carrozzo M. Rambaud JC (1992). An atypical verrucous carcinoma of the tongue arising in a patient with oral lichen planus associated with hepatitis C virus infection. Choo QL. Garzino-Demo P. Scully C. Coates EA. Gandolfo S. Goss AN. Gouffier E (1993). Elder GH. Carbone M. and systemic associations of oral lichen planus: a study of 723 patients. Barral Rodriguez S. Blood 86:1887-1892. Eisen D (2002). Cerimele D (1988). Bartoli L. Hepatology 31:182-189. Couzigou P. et al. Liver function in UK patients with oral lichen planus. Crovato M. Pityriasis rubra pilaris. Science 244:359-362. Sansonno D. Couzigou P. Oral lichen planus and hepatitis C virus infection: a fortuitous association? Arch Dermatol 133:1052-1053. Carrozzo M. J Oral Pathol Med 25:527-533. Mayer P. de Bandt M (1992). Stitle L. Giomi A. Benamouzig R. Ortonne JP (1998). Escudero A. Eur J Gastrol Hepatol 2:479-481. (1996). Oral lichen planus: patient profile. Dermatology 185:132-133. el-Kabir M. Chainani-Wu N. Porter S. et al. Prevalence of hepatitis C virus in patients with lichen planus of the oral cavity and chronic liver disease. Carbone M. Dermatology 184:229. Piga MR. Oral Oncol 33:220-225. Cornacchiulo V. Carbone M. Watson JJ (2001). et al. Hepatitis C. Carbone M. (1990). Logan RM. (2000). Laredo Vazquez Crit Rev Oral Biol Med 123 . et al. Dammacco F. Rev Esp Reumatol 24:150. Valente G. Mutations in the hemochromatosis gene. Almenar E. Kistis KG. Blood 90:776-782. Porter K. Dupin N. Bozdogan Ö. Tuci F. Garzino P. Cordoliani F. Silverman S Jr. Oral erosive lichen planus: its association with hepatitis C virus infection (abstract). Fernandez-Campillo J. Hepatology 27:289-291. Oral lichen planus in patients infected or non infected with the hepatitis C virus: the role of autoimmunity. J Am Acad Dermatol 31:1070-1072. Daoud S. Ghisetti V (1997). Cutis 67:454-456. et al. del Olmo JA. Immunochemistry of minor salivary gland biopsy specimens from patients with Sjögren's syndrome with and without hepatitis C virus. Dammacco F. d'Agay-Abensour L. Lewis C (1999). Tommasini M. Solinas A. Hepatitis C. Pivetta B. chronic liver diseases. Macnamara E (1993). Martin-Mola E. Cottoni F. el-Azhary RA (1995). et al. Corominas J. Rodriguez F. Eur J Clin Invest 31:628-638. Lichen planus during chronic hepatitis C treated with interferon alpha. Carrozzo M. Isolation of a cDNA clone derived from a blood-borne non-A. J Eur Acad Dermatol Venereol 9:S117-S118. Hepatitis C virus within a malignant lymphoma lesion in the course of type II mixed cryoglobulinemia. Lodi G. Sacco C. Racanelli V (2001). Sansonno D. Martinez-Zapico J. Erkek E. De Vita S. 14(2):115-127 (2003) The cryoglobulins: an overview. et al. Laustriat D. Pentenero M. Presse Med 21:1750-1752. lichen planus. Bradley DW. Clin Exp Dermatol 18:12-16. J Clin Pathol 21:656-660. Doutre MS. Latorre P. Pascual I. Royer P. J Am Acad Dermatol 41:787-789. (2002). Quadri R. Corte RL. Aust Dent J 45:108-114. (2000). Bertolusso G. Gastroenterol Clin Biol 17:517-518. Hatzis J. Hepatitis C virus infection in Italian patients with oral lichen planus: a prospective case-control study. Fretz C. Colombatto P. Mason DK (1968). Divano MC. Gastric mucosa as an additional extrahepatic localization of hepatitis C virus: viral detection in gastric low-grade lymphoma associated with autoimmune disease and in chronic gastritis. Carbone A. Eur J Oral Sci 108:378-382. Beylot J (1992). Hepatitis C virus infection prevalence in lichen planus: examination of lesional and normal skin of hepatitis C virus-infected patients with lichen planus for the presence of hepatitis C virus RNA. and iron overload. (1991). Sansonno D. Lichen planus and virus C hepatitis: disappearance of the lichen under interferon alfa therapy (letter).erythema multiforme in a patient with chronic hepatitis C. Carrozzo M (2001). Liver abnormalities in patients with lichen planus of the oral cavity. Lozada-Nur F. Gandolfo S. Lichen planus. Heterogeneity in the course of 6 cases treated with interferon alpha. Chosidow O. Di Bisceglie AM (1998). Beylot C. Francia di Celle P. Houghton M (1989). Colombatto P. Hepatitis C virus and lichen planus: a case-control study of 340 patients. Paganin S. Mayo Clin Proc 70:559564. Hepatocellular carcinoma in Italian patients with cirrhosis. Oral health in patients with hepatitis C virus infection: an underestimated problem? Oral Dis 7:267-270. Zervou EK. Tucci FA. Piccoli C. Scopacasa B. Bagan JV. Dalekos GN. Lancet 351:1209-1210. Lafont C. Lichen planus and chronic hepatitis C. J Hepatol 37:364-369. N Engl J Med 325:675-680. Arch Dermatol Res 280(Suppl):S55-S60. Bagan JV. The clinical features. Prevalence of hepatitis C virus in oral erosive lichen. Molecular evidence that hepatitis C virus replicates in the oral mucosa. de Franchis R. De Re V. De Vita S. Eur J Gastroenterol Hepatol 10:93. Seghieri G (1994). (1997). Carrozzo M. De Fazio C. Frances C (1997). Ferreiro M. et al. Halphen M. Beylot C. Broccoletti R. Spencer AJ. Carrozzo M. Doutre MS. Wassel AH. Br J Dermatol 144:803-808. Garnier C. Role of hepatitis C virus in "essential" mixed cryoglobulinemias and Gougerot-Sjögren's syndrome (letter). Overby LR. Ann Rheum Dis 56:390-392. Heid E (1994). disease progression and treatment responses. A prospective evaluation of dermatological side-effects during alpha-interferon therapy for chronic viral hepatitis (letter). (2001). Lissia M. Olut AI (2001). alopecia universalis and vitiligo in a patient with chronic viral hepatitis C. Brashear R. Brennan D. Sindrome de Sjögren asociado a infeccion por virus de hepatitis C: prevalencia y caracteristicas clinicas (letter). Weiner AJ. porphyria cutanea tarda. del Olmo JA. Rebora A (1992). Guardia J (1997). Tsianos EV (1998). Christodoulou D. Characterization of overt B-cell lymphomas in patients with hepatitis C virus infection. Lichen planus and hepatitis C. Clin Exp Dermatol 26:540-544. Gambus G. Tocco A. Zone JJ (1997). Gandolfo S. Lunel F. Gibson LE. Lichen planus. non-B viral hepatitis genome.

Broccoletti R. Abdelkader AA (1999). Tissot B. Apropos of a series of 50 cases (letter). Jauregui L. Gandolfo S. Miniero R. Microbiol Immunol 38:157-158. Rev Med Interne 14:1006. Antibodies to hepatitis C virus in patients with mixed cryoglobulinemia. Lee JH. Shintani Y. Popal H. Zeuzem S. et al. et al. Siso A. Hyrailles V. Lichen planus and primary biliary cirrhosis. Reichart PA. Luger TA. Trinchet JC. Should we routinely check for hepatitis B and C in patients with lichen planus or cutaneous vasculitis? East Mediterr Health J 5:71-78. Koike K. Baffoni L. Arthritis Rheum 29:577-585. Olsen I. 14(2):115-127 (2003) 124 Crit Rev Oral Biol Med . Carbone M. Successful treatment of generalized lichen planus with recombinant interferon alfa-2b. Pateron D. et al. Feucht HH. BMJ 300:227-230. Imhof M. McMurray RW. Lopez Sanchez AF. Guisset M. Virus de l'hepatite C et syndrome de Sjögren: Quel lien? (letter). Carbone M. Hayashi J. Hildebrand A. Presse Med 23:1272. Perney P. Criteria for diagnosis of Sjögren syndrome. Baddour MM. Br J Haematol 88:392394. Greco F. Curd JG. Segarra C. Arthritis Rheum 39:1166-1171. Palla P. Lancet 339:321-323. Altay O (1998). J Oral Pathol Med 31:117-120. Yoshimura E. Migliari DA (2002). et al. Vitte S (1993). Ishibashi K. Frisoni M. The prevalence of hepatitis C virus infection in patients with lichen planus in Gaziantep region of Turkey. Porter SR (1998). Kuo G. Katz M. Grote M. development and control of viral disease. Ferri C. J Clin Gastroenterol 20:346-347. J Am Acad Dermatol 33:880-883. Gimenez-Arnau A. Ikematsu H. Gastroenterol Clin Biol 19:833-836. (1992). Maccari S. Sjögren's syndrome without mixed cryoglobulinemia is not associated with hepatitis C virus infection. Carrozzo M. Clin Dermatol 18:589-600. Sicca syndrome and low-grade chronic viral hepatitis C. Erbagci Z (2000). Deny P. Oral Dis 7:271-274. Bretagne S. Fleishmann M. Fox RI. et al. Cervera R. Kirtak N. J Med Virol 58:127-131. Eur J Oral Sci 106:853-862. Gorevic PD. La Civita L. DeForges L. Am J Med 69:287-308. Rosas J. et al. Senol E. Long-term interferon-alpha therapy induces autoantibodies against epidermis. Japan. Blanc P. Sjögren's syndrome. Proposed criteria for classification. Br J Dermatol 106:699-703. Exacerbation of lichen planus but not of acute intermittent hepatic porphyria during interferon therapy in a patient with chronic hepatitis C. Minerva Stomatol 41:203-207. Kishihara Y. Lichen planus and hepatitis C-virus infection in Turkish patients. Dreno B (1996). Jubert C. Gandolfo S. (1999). Ferri S (1994). Bernard PH. Minerva Stomatol 41:209-213. Pedragosa R. Michelson P. Moretti A. Whole stimulated salivary flow in patients with chronic hepatitis C virus infection. Fox RI. Monti M. Fox RI. (1995). Figueiredo LC. Mark Y. (1980). et al. Morsi MG. Caracciolo F. J Hepatol 21:1152-1153. Han J. Dios P (2001). Lodi GL. Oral health of patients with hepatitis C virus infection: a pilot study. Levo Y. Legouffe MC. Coste J. J Eur Acad Dermatol Venereol 10:192-193. Arthritis Rheum 34:1606-1610. Stern M (2000). Berg T. Oral erosive lichen planus and chronic active hepatitis (letter). Molecular biology of the hepatitis C viruses: implications for diagnosis. Kohn R. Houghton M. Zulian P. Graham-Brown RA. Mills PR. Falasconi C. Lichen planus during lymphoblastoid interferon treatment for chronic active hepatitis C. Prose P. Goerz G. (1994). J Oral Pathol Med 23:119-122. Med Oral 6:358363. Sicca syndrome associated with hepatitis C virus infection. et al. Lichen planus and hepatitis C virus-related chronic active hepatitis. Fox R. Meynadier J. Sherlock S (1982). Castro Iglesias A. Laufs R (1994). Haddad J. Heintges T. Kolde G. Lymphocytic sialadenitis of Sjögren's syndrome associated with chronic hepatitis C virus liver disease. Rheum Dis Clin North Am 20:391-407. Ramos M. Prevalence of hepatitis C virus antibodies and evaluation of hepatitis C virus genotypes in patients with lichen planus. Jorgensen C. Choo QL (1991). Scully C. (2001). Hayashi J. Zignego AL. Ibrahim HA. No evidence of HCV infection or liver disease in British patients with oral lichen planus. Hopf U (1998). Howell FV (1986). Hernandez Vallejo G (2001). Harris KA. Camarasa JG (1995). Fornaciari G. Alayon-Lopez C. Oral lichen planus and hepatitis C virus infection. Fujie H. The prevalence of liver damage in a case load of 96 patients with oral lichen planus. Carbone M. Garcia-Patos V. Henderson L. Lichen planus and liver diseases: a multicentre case-control study. Moriya K. Casiano CA. Marzo E.R. J Eur Acad Dermatol Venereol 5:S84-S85. Yotsuyanagi H. Hepatology 14:381388. Becherer PR (1994). Ingafou M. Dermatology 192:50-55. I. Ozgoztasi. Hirata M. Pouget F. Debonne JM. Spence E. Porter SR. Gurer MA. McCruden EAB. Lichen planus and hepatitis C (abstract). The most prevalent hepatitis C virus genotypes in England and Wales are 3a and 1a. Sjögren's syndrome. Robinson CA. Munz-Gotheil C. Saito I (1994). Lupus 8:20-23. King PD. Schwarz T (1995). Garcia-Carrasco M. Apropos of 5 new cases. J Hepatol 29:1034-1035. Longombardo G. Milbradt R (1997). (1991). Hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Gallo V (1994). Presence of lichen planus during a course of interferon alpha-2a therapy for a viral chronic C hepatitis. Pawlotsky JM. Greater amount of HCV-RNA in tears compared to blood. Am J Gastroenterol 89:1047-1059. Oral lichen planus and liver pathology. Oral lichen planus and liver pathology. Gilham C. de Andrade HF Jr. Lichen planus associated with liver disease caused by hepatitis C virus. (1994). Sarkany I. Polywka S. Vidal J. Albertini G. Hepatitis C virus (HCV)-infection and oral lichen planus. Carrozzo M (1992b). Andre C. Frieling T. Oral Dis 8:4246. Nabeshima A. Pisanti S (1985). J Am Acad Dermatol 12:719. Morla RM. Zollner B. Meunier L. Immunohistochemical and serological comparison of idiopathic and hepatitis C virus-associated forms of oral lichen planus. Castells A (1996). Eur J Epidemiol 16:1159-1161. Peyron N. Carrilho FJ. Muir M. GISED (Gruppo Italiano Studi Epidemiologici in Dermatologia) (1990). Zulian P. Guijarro Guijarro B. Gallo V. Niederau C (1994). Ferri C. Ambrosini JC. Kassab HJ. Seroepidemiology of hepatitis C virus infection in hemodialysis patients and the general population in Fukuoka and Okinawa. et al. Primary Sjögren's syndrome in the elderly: clinical and immunological characteristics. Lichen planus and hepatitis C virus. Int J Oral Maxillofac Surg 27:65-66. Spacca C (1995). (1996). Mortimer PP. Klotz F. Ilter N. Inaloz HS. Boni P. J Gastroenterol 29:276-281. Carrozzo M (1992a). Gastroenterol Hepatol 19:507-510. Oral lichen planus and hepatitis C virus (HCV) infection: is there a relationship? A report of 10 cases. Dermatology 195:1-5. II. (1994). Kirby AC. Meltzer M. Mixed cryoglobulinemia: clinical aspects and long-term follow-up of 40 patients. Teo CG (1998). Kosin F. The clinicostatistical correlations between oral manifestations and liver damage. et al. Gandolfo S. Arch Dermatol 130:73-76. Celerier P. Weiner A. Teo CG (1999). Longombardo G.

Loustaud-Ratti V. Unexpected low incidence of oral lichen planus in an HCV hyperendemic area of southern Italy. Sata M. J Virol 74:1014-1017. Lo Muzio L. Int J Dermatol 39:134-139. Delaire L (1992). Mizokami M. Lomuto M. Lymphomas complicating Sjögren's syndrome and hepatitis C virus infection may share a common pathogenesis: chronic stimulation of rheumatoid factor B cells. Labrousse F. J Oral Pathol Med 26:36-39. (1991). Kameyama T (1996a). McColl MD. Favia G. Antibodies to hepatitis C virus in autoimmune liver disease: evidence for geographical heterogeneity. Mouly F. Soltani K (1984). Ferrara L. et al. Nilsson LA. Lancet 338:277-280. Piattelli A. Br J Dermatol 132:158-159. Sata M. Catala S. Revuz J (1995). Procaccini M. Proc Natl Acad Sci USA 94:233-236. Sloberg K (1984). Danon F. J Med Virol 59:277-280. (1998). Oral lichen planus and HCV infection: a clinical evaluation of 263 cases. (1995). Fedele S. Nagao Y. Liver abnormalities in patients with lichen planus. Itoh K. Itoh K. Sata M. La Nasa G. Kurume Med J 43:97-100. Carrozzo M. Clauvel 14(2):115-127 (2003) JP (1993). Mariette X. Fedele S. Gandolfo S. Lo Muzio L. et al. Nagao Y. (1996). Arthritis Rheum 36:280-281. Hepatol Res 8:173-177. HidalgoGarcia A. Lodi G. Mulargia M. Lo Muzio L (2001). Sata M. Acta Derm Venereol 64:70-73. Porter SR (1997). Marrone A. Fukuizumi K. (2001). Kameyama T (1997b). Eur J Clin Invest 26:1171-1174. Ostuni PA. Sata M. Porter SR. Soler-Sanchez T. Noguchi S. Nagao Y. Hayashi S (1995). Piattelli A. The role of hepatitis C virus in the aetiology of nonHodgkins lymphoma: a regional association? Leuk Lymphoma 26:127-130. Artese L. Immunological evaluation in oral lichen planus with chronic hepatitis C. Lichen planus and the liver. Nagao Y. Gouya L. Mokni M. et al. Puppin D Jr. Piattelli A. High prevalence of hepatitis C virus antibody and RNA in patients with oral cancer. Soria P. Itoh K. Lichen planus and hepatitis C virus in the Northern Kyushu region of Japan. HCV-genotypes in Italian patients with HCV related oral lichen planus. Marasca R. Gómez-Díez S. et al. Luppi M. Manjón-Haces JA. et al. Acta Derm Venereol 81:223. Benkhraba F. Roujeau JC. Antibodies to epithelial components in oral lichen planus (OLP) associated with hepatitis C virus (HCV) infection. Andriulli A. Olsson R. J Oral Pathol Med 29:3942. Chuang TY. Lodi G. Tanikawa K. Cascavilla I. Testa NF. Mobacken H. Oral cancer and hepatitis C virus (HCV): can HCV alone cause oral cancer?—a case report. Cottoni F. Lodi G. Ballardini G. J Gastroenterol 32:324-329. Pizzati A. Bogard C. Oral Dis 3:77-81. (2001). Rev Med Interne 13:S346. Hepatitis C virus infection: review and implications for the dentist. Nagao Y. Ferrari MG. Venezia F. Monk B (1985). Oral Surg Oral Med Oral Pathol Oral Radiol Endod 86:8-22. Autoimmune liver disease complicating Sjögren's syndrome. Masaki N. Gambari PF (1991). Br J Dermatol 132:897-900. Hepatitis C virus and Sjögren's syndrome. Nagao Y. Additional neoplasms and HCV infection in lowgrade lymphoma of MALT type. Noguchi S. Zenarola P. Kameyama T. Sialadenitis histologically resembling Sjögren syndrome in mice transgenic for hepatitis C virus envelope genes. Vacca A. Sata M. Various extrahepatic manifestations caused by hepatitis C virus Crit Rev Oral Biol Med 125 . et al. Harada H. Fox P (1995). (1997a). Uneven distribution of hepatitis C virus quasispecies in tissues from subjects with end-stage liver disease: confounding effect of viral adsorption and mounting evidence for the presence of low-level extrahepatic replication. Lamoril J. Teo CG. Kameyama T (1995a). Pawlotsky JM. Liozon E. Mignogna MD. Itoh K. Perez-Alvarez R. Quantitative analysis of HCV RNA and genotype in patients with chronic hepatitis C accompanied by oral lichen planus. Nagao Y. Di Bisceglie AM. Jaccard A. Ann Rheum Dis 60:1007-1011. Abe K. Ruoppo E. Association of porphyria cutanea tarda and lichen planus in a patient with chronic hepatitis C virus infection. Oral lichen planus: different clinical features in HCVpositive and HCV-negative patients. Suzuki H. Mariette X (2001). et al. HLA antigen distribution in different clinical subgroups demonstrates genetic heterogeneity in lichen planus. Mignogna RE. Puy H. et al. Riche A. et al. Schenmetzler C. J Oral Pathol Med 26:138-134. Oral Oncol 34:239-246. J Am Acad Dermatol 12:122-124. Ruoppo E. Ongaro G. Hepatology 27:848-852. Lack of hepatitis C virus replication intermediate RNA in diseased skin tissue of chronic hepatitis C patients. Gougerot-Sjögren. J Am Acad Dermatol 24:792. Favia G. Pawlotsky JM. Olsen I. Vázquez-López F. (1997). Gastroenterology 121:15281529. J Oral Pathol Med 24:354-360. Lo Russo L. Carrozzo M. Prevalence and characteristics of Sjögren's sindrome or sicca sindrome in chronic hepatitis C virus infection: a prospective study. Br J Haematol 94:373-375. Kameyama T (1997c). Lo Russo L. Longo G. The possible association between oral lichen planus and oral squamous cell carcinoma: a clinical evaluation on 14 cases and a review of the literature. Eur J Clin Invest 25:910-914. Incidence of liver disease in chronic lichen planus of the mouth. J Oral Pathol Med 26:381-384. Bucci E (1998). Sata M. J Hepatol 22:599. Lo Muzio L. Mignogna MD. Lenzi M. Fukuda T. Barozzi P. Nagao Y. GB virus infection in patients with oral cancer and oral lichen planus. Korkij W. Johnson PJ. Andant al. Lodi G. D'Amico E. syndrome sec et hepatite C (abstract). (1999). Rogez S. J Rheumatol 28:2245-2251. Hepatitis C virus infection and lichen planus: a short review. Absence of hepatitis C viral infection among patients with primary Sjögren's syndrome (letter). Tanikawa K. Rakela J (2000). Tanikawa K. Development and exacerbation of oral lichen planus during and after interferon therapy for hepatitis C. Zerbib M. Rybojad M. Loustaud-Ratti V. Suzuki H. Bucci E (2000). Anti-hepatitis C virus serology in primary Sjögren's syndrome: no evidence of cross-reactivity between rheumatoid factor and specific viral proteins. Nowicki M. Mignogna MD. Eur J Clin Invest 26:495-498. Nippon Rinsho 10:2530-2535. Sata M. Vicarioto M. Tait RC. Tajiri N. Radkowski M. McFarlane BM. Scully C (1998). High incidence of oral precancerous lesions in a hyperendemic area of hepatitis C virus infection. A retrospective case-control study. Teo CG. Laskus T. Djian R. Smith HM. Quadri R. et al. Cumming RL. Hallett R. D'Amico E. Hogg RB (1997). Hepatitis C virus-associated oral lichen planus: no influence from hepatitis G virus co-infection. Nagao Y. Ono N. Fukuizumi K. et al. (2000). Marson P. et al. Schaeffer A. Mignogna MD. Wang LF. (1996b). Tanikawa K. J Am Acad Dermatol 11:609-615. et al. Vidal E. (1991). Harris K. Clin Exp Rheumatol 9:661-662. Lichen planus and hepatitis C virus (letter). Sata M. Lodi G. Carcassi C. Ide T. Epidemiology of hepatitis C and G in sporadic and familial porphyria cutanea tarda. Tanikawa K. McFarlane IG. Singer IO. Kameyama T (1995b). Tanikawa K. Porter SR (1997a). Carbone R. Kameyama T (1996c). McNeil IR. (1997b). Bucci E (1998). Adverse cutaneous reactions to interferon Alfa-2b plus ribavirin therapy in patients with chronic hepatitis C virus (letter). Int J Dermatol 37:575-578. (1999). Mangia A.

Mucocutaneous lichen planus induced by a second treatment with high-dose interferon-alpha in a patient with chronic viral hepatitis C (letter). Konrad SS. Pirisi M. Trejo O. (1998). Gay JD. Duval J. J Med Virol 64:183-189. Voisin MC. 2001. Immunological disorders in C virus chronic active hepatitis: a prospective case-control study. Ribero ML. Rossi L. Gastroenterology 104:903-905. Monges D. et al. Intrator L. Torolli-Serabian I. (1994a). Nagao Y. Sanchez-Perez J. Oral Dis 2:183-184. de la Red G. et al. (1995b). Gastroenterol Clin Biol 18:1051. Rebora A. J Am Acad Dermatol 36:1023-1025. Rosas J. Pawlotsky JM. Rebora A (1994). Hepatology 19:841-848. et al. September 2-5. Lichen planus and chronic active hepatitis. Lodi G. Hepatitis C virus in dermatology. Br J Dermatol 107:616. Mellor J. (2001). et al. Previous tuberculosis. Nakanishi T. Powell FC. Bergfeld WF (1997). Carrozzo M. Ueno T (2000b). Finzi AF. Hepatology 21:305-312. A detection of genomic. Cameron S. Rebora A (1992). Garcia-Diez A (1996). Fernandez-Herrera J. LopezAlcorocho JM. Gastroenterol Clin Biol 17:764. Roy K. Lichen planus and chronic active hepatitis. Salivary gland lesions in patients with chronic hepatitis C (abstract). Oral Dis 2:125-128. A retrospective survey. Ueno T (2000c). Gerolami A (1994). Int J Dermatol 33:221-222. Sata M. Ricci R. Kumar N (1997). High incidence of extrahepatic manifestations in an HCV hyperendemic area. et al. (1994). Elston DM (1998). A review. Andre C. Poet JL. Di Stefano R. Constant T. Katayama K. (2001). Clinical considerations and statistical analysis on 100 patients with oral lichen planus. Michel P. Hepatitis C viremia in erosive and classic lichen planus (abstract). Localization of hepatitis C virus antigens in liver and skin tissues of chronic hepatitis C virus-infected patients with mixed cryoglobulinemia. (1999). J Am Acad Dermatol 11:142-143. de las Heras ME. Campagnoli S. Papini M. Rogers RS. et al. Powell FC. Petracca R. Zerbini A. Voisin MC. Good T. Ochsendorf FR. Nagao Y. Rebora A. Lichen planus as a side effect of HBV vaccination. Oral Dis 5:270-277. Leopolder-Ochsendorf A. Chronic active hepatitis and lichen planus. p. Acta Derm Venereol 62:351-352. Diaz PJ (1995). Acta Derm Venereol 75:87. Mild sialoadenitis: a common finding in patients with hepatitis C virus infection. J Dermatol 22:461-462. Cerioni S. Zarski JP. Scand J Gastroenterol 29:940-942. Borque MJ. Kage M. Roudot-Thoraval F. Revuz J. Oleaga JM. Pawlotsky JM. Vescovi P. Iacobelli AR. Moriya T. Int J Dermatol 31:392395. Porter SR. hepatitis c virus and lichen planus. Bartolome J. Krawczynski K. Benchiki H. Tanaka J. Krawczynski K. Bagg J (2000). Generalized lichen planus associated with primary biliar cirrhosis which resolved after liver transplantation (letter). (1995). Rebora A. Lichen planus and HCV genotypes. (2000). J Eur Acad Dermatol Venereol 5:S84. Dammacco F (1995). Teo CG (1996). Hepatology 29:536-542. Histopathological and immunohistochemical study of oral lichen planus-associated HCV infection. Predominance of HCV type 2a in saliva from intravenous drug users. Garnier PP (1994). Noguchi S. Sudden onset of oral ulcerative lichen in a patient with chronic hepatitis C on treatment with alfa-interferon. Kameyama T. De Castro M. Paris. Eur J Intern Med 11:277-282. Garcia-Carrasco M. Cutis 61:90-92. Cornacchiulo V. Djaghri N. Oral lichen planus infiltrating T cells: a pathogenetic role for HCV-specific T cell responses? (abstract). Schmitt EC. Chronic hepatitis C and Sjögren's syndrome. Simmonds P. Ramos-Casals M. Gastroenterology 119:882-883. Dickson ER (1982). Sassigneux P. High incidence of oral lichen planus in an HCV hyperendemic area. Minerva Stomatol 49:393-398. Camisa C. McCarron B. primary biliary cirrhosis and penicillamine (letter). J Oral Pathol Med 29:259-266. Mozzanica N. Sata M. (2001). Rubbia-Brandt L. Ben Yahia M. et al. Tagger A. Gandolfo S. et al. Pawlotsky JM. 34. Hepatology 20:248A. Rodriguez-Inigo E. Sata M. Joly P. (1994b). Rogers RS 3rd (1984). A report of 10 cases. Schissel DJ. Bagot M (1995a). Perreard M. Leone N. Oral Dis 4:155-156. Acta Derm Venereol 64:52-56. Rongioletti F (1984). Hepatitis viruses and lichen planus. Lospalluti M. Lodi G. (2002). Scully C. Gardeazabal J. Bagg J. Nunez M. Fabris C. Chandler K. Fukuizumi K. Ortiz-Movilla N. Roy K. Lichen planus. Hepatitis C virus infection mimicking primary Sjögren syndrome. Vanni M. Kameyama T. Nagao Y. J Rheumatol 21:1376-1377. Bagg J (1999). Porter SR. Eruptive mucocutaneous lichen planus during treatment of chronic hepatitis C with interferon alpha (letter). Quadri R. Br J Dermatol 134:715-719. A causal or casual link? Panminerva Med 42:77-81. Colin R (1993). A clinical and immunologic description of 35 cases. Penna A. Int J Mol Med 4:621-625. Lack of association between hepatitis C virus and Sjögren's syndrome. Kinoshita M. et al. Medicine (Baltimore) 80:1-8. Kumagai J. Oral erosive lichen planus with epidermolytic hyperkeratosis during interferon alfa-2b therapy for chronic hepatitis C virus infection. Manfredi M. Dhumeaux D. IFN-alpha cream in the treatment of oral lichen planus. Rongioletti F. Miralles ES. Cervera R. et al. Nagao Y. Replay. Ferraccioli G. Bruni PL. Pedersen A (1998). Ueno T (2000a). Arrieta JJ. Canepa A (1982). Lichen planus and the liver. Pileri P. Pellicano R. Detection of hepatitis C virus RNA in oral lichen planus and oral cancer tissues. Pawlotsky JM. Liberati F (1994). Science 282:938934. Clin Lab 46:251-254. Arch Dermatol 130:1328-1329. Development of squamous cell carcinoma in hepatitis C virus-associated lichen planus. Negro F. Ryu F. Colasanto S (2000). Palmas F. Dermatology 198:1-2. Hepatitis C virus and oral lichen planus/lichenoid reactions: lack of evidence for an association. Lichen planus associated with hepatitis C. Angeli-Besson C. TT virus detection in oral lichen planus lesions. Drago F. Del Ninno ML. Scott C. Buezo GF. Pedersen A (1996). Hepatitis C virus and oral disease: a critical review. Rongioletti F. Oral Oncol 33:58-59. Protzer U. Sanz de Galdeano C. Pellet C. Exacerbation of lichen planus during interferon alfa2a therapy for chronic active hepatitis C. Dhumeaux D. Soardo G. Holtermuller KH (1993). et al. Hepatol Res 22:27-36. Sansonno D. Lichen planus and hepatitis C virus: prevalence and clinical presentation of patients with lichen planus and hepatitis C virus infection. Abnormal EBV immune status in oral lichen planus. Parodi A (1999). Ledo A (1995). Casqueiro M. Roy KM. Bettacchi A. Appearance of oral erosive lichen planus during interferon alfa-2a therapy for chronic active hepatitis C. Pilli M. Arch Dermatol 131:1185-1193. Schlesinger TE. Binding of hepatitis C virus to CD81. Dickson EM.infection. Pithie A (1998).and minusstrand of hepatitis C virus RNA in the liver of chronic hepatitis C patients by strand-specific semiquantitative reverse-transcriptase polymerase chain reaction. Uematsu Y. Dickson ER. Mondelli M. J Med Virol 54:271-275. Br J Dermatol 133:666-667. 14(2):115-127 (2003) 126 Crit Rev Oral Biol Med . Duval J. Proceedings of the 8th International Symposium on Hepatitis C Virus and Related Viruses. et al. Falugi F. Galli G.

Stephens P. Watanabe K. Hepatology 28:921-925. Mavridis AK. van der Meij EH. J Hepatol 26:1200-1206. Sorensen HT. Laxenaire A. Carrozzo M (2000). Gamberini S. Sanches M (2000). Desinan L. Katsuoka K (1997). UVA and interferon-alfa therapy in a patient with lichen planus and chronic hepatitis C (letter). Acta Derm Venereol 79:378-379. (1995). Szodoray P. Bozza A. Semin Liver Dis 20:1-16. Vitali C. Wasley A. Gutekunst K. Boccia S. Clin Exp Rheumatol 12:227-233. Eriksson S. Bardus P. Taliani G. Venturini D. Management of oral lichen planus. Oral lichen planus induced by interferon-alpha-N1 in a patient with hepatitis C (letter). Sciuto M. Areias J. Toure G. (1992). J Intern Med 245:127-132. Youinou P. Tanei R. Potts AJ. Ann Med Interne (Paris) 146:247-250. Hepatitis C virus propagates in salivary glands. McKee JI. Scheffer P (1998). Avellini C. et al. Rodriguez-Pardo D. (1997). Varela P. J Oral Pathol Med 29:255-258. MatasPericas L. Castano V. J Med Virol 54:80-85. J Dermatol 24:20-27. Carlson J. et al. Hepatitis C virus infection of salivary gland epithelial cells. Cabane J. Mizokami M. Thulstrup AM. Kumada T. Pirisi M. Pennica A. Association of Gougerot-Sjögren syndrome and viral hepatitis C. et al. Verbaan H. Ann Intern Med 127:423-428. Wiesenfeld D. Olsen JH. Neri R. Hepatitis C virus infection. Nishiyama S (1995). Histopathology 30:41-48. Huault M. Rev Stomatol Chir Maxillofac 99:49-51. Clinical and histopathological analysis of the relationship between lichen planus and chronic hepatitis C. Kien MC. Lichen and hepatitis C. van der Waal I (2000). (1997). Loustaud V. Selva-O'Callaghan A. Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma. and non-Hodgkin's lymphoma. Tanei R. Lack of evidence. Toyoda H. Horanyi M. J Dermatol 22:316-323. Quasispecies nature of hepatitis C virus (HCV) in patients with chronic hepatitis C with mixed HCV subtypes. Fukuda Y. Am J Clin Dermatol 1:287-306. Lim SH (1997). A statistical epidemiological study of a possible correlation between serum transaminase levels and viral hepatic pathology markers and lichen planus orale. Neglia V. Risk of liver and other types of cancer in patients with cirrhosis: a nationwide cohort study in Denmark. T-cell receptor V beta usage by lesional lymphocytes in oral lichen planus. Mota F. Frider B. Busciolano M. Ferraccioli GF. Gullini S (1993). Patten DW. Arrouasse C. Hamburger J. Arch Dermatol 135:1000-1001. Yamamoto N (1992). Thomas DW. Celestino D. Canelhas A. Femiano F (1997). (1998). Linet M. (1997). Anti-hepatitis C virus antibodies in primary Sjögren's syndrome: false positive results are related to hyper-gammaglobulinaemia. Takamatsu K. (1999). Liozon F. Epidemiology of hepatitis C: geographic differences and temporal trends. Minerva Stomatol 46:97-102. Lichen planus and Sjögrentype sicca syndrome in a patient with chronic hepatitis C. Apropos of 6 cases (letter). Rheumatol Int 21:6-9. Larsson A. Clin Exp Rheumatol 10:103-104. Suspected multiviral involvement in primary Sjögren's syndrome. Vidal E. Serfaty L. Hepatitis C virus infection and oral lichen planus: a report from The Netherlands. Alter MJ (2000). Csepregi A. Serpico R. Liedholm R. Poliandri G. Okayasu I. Lichen planus and liver disease: how strong is the association? J Oral Pathol 14:224-226. Hejjas M. (1999). Badolato MC. Bosch-Gil JA. et al. Ohta Y. Lichen planus is not associated with hepatitis C virus infection in patients from north west England. Friis S. Zeher M (2001). J Oral Pathol Med 26:105-109. Coulson ICH (1999). Scully C. Chronic lymphocytic sialoadenitis in HCV-related chronic liver disease: comparison of Sjögren's syndrome. Sanchez-Sitjes L. Extrahepatic manifestations of chronic hepatitis C infection and the interrelationship between primary Sjögren's syndrome and hepatitis C in Swedish patients. Zuckerman E. et al. et al. Mellemkjaer L. Verdier M. Wattiaux MJ. Manthorpe R. Sjögren's syndrome. Strumia R. J Infect Dis 165:973-974. Solans-Laque R. et al. et al. Tsioufas AG. (1998). Eisen D. Chohela E (1999). Levine AM. Andreani T. Denis F (1994). Ranger S. Greco F. Stephens M. el Kom M (1985). Scully C. Katano Y. et al. Levy JD. Int J Dermatol 32:386. Tucker SC. Douer D. Arthritis Rheum 42:2489-2490.Scott CA. Koyanagi Y. Takayama T. Nakano I. High prevalence of cutaneous reactions to interferon alfa plus ribavirin combination therapy in patients with chronic epatitis C virus. 14(2):115-127 (2003) Crit Rev Oral Biol Med 127 . Jouan-Flahault C. Int J Dermatol 39:239-240. Study of hepatitis C virus infection in 213 Hungarian patients with Sjögren's syndrome. Sookoian S. Zuckerman T.